tiprankstipranks
Trending News
More News >
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
US Market

Corbus Pharmaceuticals (CRBP) Income Statement

Compare
2,509 Followers

Corbus Pharmaceuticals Income Statement

Last quarter (Q3 2025), Corbus Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Corbus Pharmaceuticals's net income was $-23.34M. See Corbus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 881.71K$ 3.94M
Gross Profit
$ -600.00K$ 0.00$ -1.49M$ -757.53K$ 3.94M
Operating Expenses
$ 48.12M$ 45.08M$ 33.35M$ 55.23M$ 126.75M
Depreciation and Amortization
$ 600.00K$ 641.00K$ 1.49M$ 1.64M$ 1.69M
EBITDA
$ -37.74M$ -40.10M$ -38.73M$ -54.35M$ -121.12M
Operating Income
$ -48.72M$ -45.08M$ -34.84M$ -55.99M$ -122.81M
Other Income/Expenses
$ 8.51M$ 474.00K$ -7.51M$ 10.35M$ 11.54M
Pretax Income
$ -40.21M$ -44.60M$ -42.35M$ -45.64M$ -111.27M
Net Income
$ -40.21M$ -44.60M$ -55.83M$ -45.55M$ -111.27M
Per Share Metrics
Basic EPS
$ -3.68$ -10.31$ -10.15$ -11.11$ -42.74
Diluted EPS
$ -3.68$ -10.31$ -10.15$ -11.11$ -42.74
Weighted Average Shares Outstanding
10.91M 4.33M 4.17M 4.10M 2.60M
Weighted Average Shares Outstanding (Diluted)
10.91M 4.33M 4.17M 4.10M 2.60M
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History